Search Results - "Wingerchuk, Dean M"
-
1
Neuromyelitis Spectrum Disorders
Published in Mayo Clinic proceedings (01-04-2017)“…Abstract The understanding of neuromyelitis optica spectrum disorder (NMOSD) has evolved substantially since its initial description over a century ago. The…”
Get full text
Journal Article -
2
Multiple Sclerosis: Current and Emerging Disease-Modifying Therapies and Treatment Strategies
Published in Mayo Clinic proceedings (01-02-2014)“…Abstract Multiple sclerosis (MS) is a chronic inflammatory demyelinating central nervous system disease that typically strikes young adults, especially women…”
Get full text
Journal Article -
3
MRI of the relevant domain should be performed to confirm whether clinical symptoms represent an attack of NMOSD: Yes
Published in Multiple sclerosis (01-01-2024)Get full text
Journal Article -
4
Disease-modifying therapies should be stopped in NMOSD patients in remission – Commentary
Published in Multiple sclerosis (01-08-2019)Get full text
Journal Article -
5
The emerging relationship between neuromyelitis optica and systemic rheumatologic autoimmune disease
Published in Multiple sclerosis (01-01-2012)“…Neuromyelitis optica (NMO) and NMO spectrum disorders (NMOSD) are associated with autoantibodies that target aquaporin-4 and, in many cases, multiple other…”
Get full text
Journal Article -
6
Epidemiology of Neuromyelitis Optica Spectrum Disorder and Its Prevalence and Incidence Worldwide
Published in Frontiers in neurology (26-06-2020)“…Neuromyelitis optica spectrum disorder (NMOSD) is an uncommon inflammatory disease of the central nervous system, manifesting clinically as optic neuritis,…”
Get full text
Journal Article -
7
Smoking: effects on multiple sclerosis susceptibility and disease progression
Published in Therapeutic Advances in Neurological Disorders (01-01-2012)“…Multiple sclerosis (MS) is associated with both genetic and environmental factors that influence disease susceptibility. Exposure to cigarette smoke is…”
Get full text
Book Review Journal Article -
8
Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study
Published in Lancet neurology (01-06-2013)“…Summary Background Complement activation after binding of an IgG autoantibody to aquaporin 4 (AQP4) is thought to be a major determinant of CNS inflammation…”
Get full text
Journal Article -
9
Epidemiology of aquaporin-4 autoimmunity and neuromyelitis optica spectrum
Published in Annals of neurology (01-05-2016)“…Objective Neuromyelitis optica (NMO) and its spectrum disorders (NMOSD) are inflammatory demyelinating diseases (IDDs) with a specific biomarker,…”
Get full text
Journal Article -
10
Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders
Published in JAMA neurology (01-01-2015)“…Short transverse myelitis (STM; <3 vertebral segments) is considered noncharacteristic of neuromyelitis optica (NMO) spectrum disorders (NMOSDs)…”
Get more information
Journal Article -
11
Predictive models in the diagnosis and treatment of autoimmune epilepsy
Published in Epilepsia (Copenhagen) (01-07-2017)“…Summary Objective To validate predictive models for neural antibody positivity and immunotherapy response in epilepsy. Methods We conducted a retrospective…”
Get full text
Journal Article -
12
Eculizumab monotherapy for NMOSD: Data from PREVENT and its open-label extension
Published in Multiple sclerosis (01-03-2022)“…During PREVENT (a phase 3, randomized, double-blind, placebo-controlled, time-to-event study) and its open-label extension (interim analysis), 33 adults with…”
Get full text
Journal Article -
13
The spectrum of neuromyelitis optica
Published in Lancet neurology (01-09-2007)“…Summary Neuromyelitis optica (also known as Devic's disease) is an idiopathic, severe, demyelinating disease of the central nervous system that preferentially…”
Get full text
Journal Article -
14
Estriol combined with glatiramer acetate for women with relapsing-remitting multiple sclerosis: a randomised, placebo-controlled, phase 2 trial
Published in Lancet neurology (01-01-2016)“…Summary Background Relapses of multiple sclerosis decrease during pregnancy, when the hormone estriol is increased. Estriol treatment is anti-inflammatory and…”
Get full text
Journal Article -
15
Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica
Published in Neurology (01-10-2013)“…OBJECTIVE:To 1) determine, using contemporary recombinant antigen–based assays, the aquaporin-4 (AQP4)–immunoglobulin G (IgG) detection rate in sequential sera…”
Get full text
Journal Article -
16
Aquaporin-4 serostatus does not predict response to immunotherapy in neuromyelitis optica spectrum disorders
Published in Multiple sclerosis (01-11-2018)“…Background: Debate exists about whether neuromyelitis optica spectrum disorder seronegative disease represents the same immune-mediated attack on astrocytic…”
Get full text
Journal Article -
17
The spectrum of acute cardiopulmonary events associated with multiple sclerosis exacerbations
Published in Multiple Sclerosis Journal (01-05-2019)“…Diverse acute neurological injuries may cause acute cardiopulmonary events including neurogenic pulmonary edema (NPE) and neurogenic stunned myocardium (NSM)…”
Get full text
Book Review Journal Article -
18
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
Published in The Lancet (British edition) (11-12-2004)“…Neuromyelitis optica is an inflammatory demyelinating disease with generally poor prognosis that selectively targets optic nerves and spinal cord. It is…”
Get full text
Journal Article -
19
Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis
Published in Annals of neurology (01-03-2006)“…Objective We investigated whether neuromyelitis optica (NMO) IgG seropositivity at the initial presentation of longitudinally extensive transverse myelitis…”
Get full text
Journal Article -
20
Neuromyelitis optica spectrum disorder diagnostic criteria: Sensitivity and specificity are both important
Published in Multiple sclerosis (01-02-2017)Get full text
Journal Article